Back
EyePoint Pharmaceuticals Stock Predictions
Mode Mobile Could be Next in Line"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
40
EYPT
EyePoint Pharmaceuticals
Last Price:
$5.69
Seasonality Move:
9.92%
7 Day Trial
ALL ACCESS PASS
$
7
Mode Mobile Could be Next in Line
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.EyePoint Pharmaceuticals Stock Forecast
-
Over the next 52 weeks, EyePoint Pharmaceuticals has on average historically risen by 21.1% based on the past 20 years of stock performance.
-
EyePoint Pharmaceuticals has risen higher in 8 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
-
Is EyePoint Pharmaceuticals Stock Undervalued?The current EyePoint Pharmaceuticals [EYPT] share price is $5.68. The Score for EYPT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
EYPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will EyePoint Pharmaceuticals Stock Go Up Next Year?
-
Over the next 52 weeks, EyePoint Pharmaceuticals has on average historically risen by 21.1% based on the past 20 years of stock performance.
EyePoint Pharmaceuticals Stock Rating
Sell
40
EyePoint Pharmaceuticals (EYPT)
is a Sell
Is EyePoint Pharmaceuticals overpriced?
-
EyePoint Pharmaceuticals has risen higher in 8 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
EyePoint Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
eyepointpharma.com
52-Week Data
52-Week High:
21.26
52-Week Low:
3.91
Prediction Charts
Market Cap:
390M
Price in USD:
5.68
Volume:
557.9K
Beta:
1.88
Technical Analysis
SMA50:
6.03
SMA100:
7.04
SMA200:
8.18
52-Wk Change:
-72.9%
Stock Predictions
-
Is EyePoint Pharmaceuticals stock public?Yes, EyePoint Pharmaceuticals is a publicly traded company.
-
What is the EyePoint Pharmaceuticals stock quote today?The EyePoint Pharmaceuticals stock price is 5.68 USD today.
-
How to buy EyePoint Pharmaceuticals stock online?You can buy EyePoint Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-31 | 5.63 | 5.42 | 5.71 | 5.34 |
| Apr-1 | 5.36 | 5.05 | 5.39 | 5.00 |
| Apr-2 | 5.00 | 5.37 | 5.42 | 4.92 |
| Apr-3 | 5.02 | 4.98 | 5.13 | 4.83 |
| Apr-4 | 5.10 | 4.60 | 5.10 | 4.51 |
| Apr-7 | 4.50 | 4.62 | 4.72 | 4.19 |
| Apr-8 | 4.79 | 4.13 | 4.86 | 4.09 |
| Apr-9 | 4.02 | 4.56 | 4.89 | 3.91 |
| Apr-10 | 4.49 | 4.81 | 4.85 | 4.15 |
| Apr-11 | 4.75 | 5.38 | 5.42 | 4.70 |
| Apr-14 | 5.51 | 5.71 | 5.76 | 5.14 |
| Apr-15 | 5.70 | 5.67 | 5.86 | 5.45 |
| Apr-16 | 5.65 | 5.55 | 5.70 | 5.43 |
| Apr-17 | 5.55 | 5.68 | 5.74 | 5.37 |
EyePoint Pharmaceuticals Earnings
EyePoint Pharmaceuticals Earnings Report: Per Share EyePoint Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
EyePoint Pharmaceuticals Forecast Revenue Growth
EyePoint Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for EyePoint Pharmaceuticals and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.22 per share, an increase next quarter of $0.10 per share, an increase this year of $0.11 per share, and a decrease next year of $0.90 per share.
* EyePoint Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.